Astra Buying Bristol Makes No Sense, Fazeli Says
AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would …
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for SAM skewed neutral (14 of 23 scored calls).
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| Fisher Cynthia A | Director | Apr 02 '26 | Option Exercise | 245825.0 |
| MICHAEL SPILLANE | Officer | Nov 04 '25 | Proposed Sale | 642043.0 |
| Spillane Michael | Director | Nov 04 '25 | Sale | 642036.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing SAM price, sentiment, and trend
AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would …
A fourth wave of attacks on Coldcard-generated bitcoin wallets has pushed total losses toward $114 million since July 30. The …
On the latest episode of Equity, we discuss why Sam Altman has calling on the industry to "pace the rate …
OpenAI's CEO seemed excited to share a "cool use case" for parents.
OpenAI's Sam Altman and Nvidia's Jensen Huang were among tech leaders in Washington, D.C., ahead of a deadline the White …
After years of pushing full speed ahead on AI, OpenAI CEO Sam Altman says maybe it’s time for the AI industry to “pace” itself. …
Multi-Provider AI Analysis